Physician profile
Lily Hipp
NPI 1548764947
$6,864.16
in general payments reported to CMS, 2019-2025
16 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $133 · 2021: $2,121 · 2022: $2,356 · 2023: $679 · 2024: $920 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,171.56 | 2019-2025 | Hydrus Microstent, Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,713.97 | 2021 | |
| Abbvie INC. | $1,079.01 | 2022-2025 | |
| Glaukos Corporation | $794.76 | 2022-2025 | Idosetr, Radius, Istent Trabecular Micro-Bypass System Model Is3 |
| Rayner Intraocular Lenses Limited | $143.67 | 2024-2025 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| New World Medical,INC. | $137.88 | 2023-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Genentech USA, INC. | $137.66 | 2022 | |
| Ivantis, INC | $132.91 | 2021 | |
| Regeneron Pharmaceuticals, INC. | $125.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $115.01 | 2020 | |
| Sight Sciences, INC. | $113.58 | 2023-2024 | Omni Surgical System |
| Rxsight INC | $69.21 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Bausch & Lomb Americas INC. | $59.68 | 2022-2025 | Scoutpro Osmolarity System, Vyzulta |
| Oyster Point Pharma, INC. | $33.58 | 2024 | Tyrvaya, Ryzumvi |
| Dompe US, INC. | $19.32 | 2025 | Oxervate |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $17.36 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lily Hipp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.